Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9
- Application ID: EP13305762
- Status: █ APPLICATION REFUSED
This EP application has the IPC class C07 (ORGANIC CHEMISTRY). Sanofi-Aventis Deutschland GmbH is specialized in C07. Sanofi-Aventis Deutschland GmbH is specialised in C07 (ORGANIC CHEMISTRY). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.
- 10.12.2014 - Publication A1 (EP2810955)